Scarica l'app Stockscreener
2.88
1.71%
-0.05
Dopo l'orario di chiusura:
2.87
-0.010
-0.35%
Precedente Chiudi:
$2.93
Aprire:
$2.94
Volume 24 ore:
110.34K
Relative Volume:
0.44
Capitalizzazione di mercato:
$56.17M
Reddito:
-
Utile/perdita netta:
$-30.15M
Rapporto P/E:
-0.72
EPS:
-4
Flusso di cassa netto:
$-21.66M
1 W Prestazione:
-3.68%
1M Prestazione:
-15.79%
6M Prestazione:
-8.28%
1 anno Prestazione:
+22.03%
Intervallo 1D:
$2.8231
$2.96
Intervallo di 1 settimana:
$2.8231
$3.15
Portata 52W:
$1.10
$6.01
Nrx Pharmaceuticals Inc Stock (NRXP) Company Profile
Nome
Nrx Pharmaceuticals Inc
Settore
Industria
Telefono
484-254-6134
Indirizzo
1201 ORANGE STREET, WILMINGTON
Confronta NRXP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NRXP
Nrx Pharmaceuticals Inc
|
2.88 | 57.15M | 0 | -30.15M | -21.66M | -4.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.41 | 118.34B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.14 | 60.31B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
330.55 | 42.35B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
598.79 | 36.43B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
305.74 | 31.87B | 3.81B | -644.79M | -669.77M | -6.24 |
Nrx Pharmaceuticals Inc Stock (NRXP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-02 | Iniziato | BTIG Research | Buy |
Nrx Pharmaceuticals Inc Borsa (NRXP) Ultime notizie
Published on: 2025-07-29 21:24:51 - metal.it
NRx Pharmaceuticals (NASDAQ: NRXP) CEO to Join Fireside Chat at BTIG Virtual Biotechnology Conference - TipRanks
NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Join Fireside Chat at BTIG Virtual Biotech Conference July 2930, 2025 - Nasdaq
NRx Pharmaceuticals Teams with Yale Expert to Reveal Latest CNS Treatment Innovations at BTIG Conference - Stock Titan
Wyckoff Accumulation Phase Possible in NRx Pharmaceuticals Inc.High Win Rate Trading Opportunities Detected - metal.it
What makes NRx Pharmaceuticals Inc. stock price move sharplyStable Entry High Return Opportunities in Focus - metal.it
How many analysts rate NRx Pharmaceuticals Inc. Equity Warrant as a “Buy”Free Stock Outlook That Work - jammulinksnews.com
How many analysts rate NRx Pharmaceuticals Inc. as a “Buy”Achieve breakthrough performance with smart picks - jammulinksnews.com
What are NRx Pharmaceuticals Inc. company’s key revenue driversBuild wealth faster with disciplined trading - jammulinksnews.com
Does NRx Pharmaceuticals Inc. stock perform well during market downturnsFree Predictions - jammulinksnews.com
Should I hold or sell NRx Pharmaceuticals Inc. stock in 2025Capitalize on market trends with expert guidance - jammulinksnews.com
What makes NRx Pharmaceuticals Inc. Equity Warrant stock price move sharplyCapitalize on market momentum for maximum gains - jammulinksnews.com
How volatile is NRx Pharmaceuticals Inc. stock compared to the marketCapitalize on market trends with confidence - jammulinksnews.com
What are the latest earnings results for NRx Pharmaceuticals Inc.Amplify your gains with low-risk picks - jammulinksnews.com
How does NRx Pharmaceuticals Inc. Equity Warrant compare to its industry peersFree Consultation - jammulinksnews.com
How strong is NRx Pharmaceuticals Inc. Equity Warrant company’s balance sheetFree Daily Trading Room Entry - jammulinksnews.com
What are NRx Pharmaceuticals Inc. Equity Warrant company’s key revenue driversHarness the power of proven investment plans - jammulinksnews.com
Why is NRx Pharmaceuticals Inc. stock attracting strong analyst attentionGet daily expert analysis on top stocks - jammulinksnews.com
How does NRx Pharmaceuticals Inc. compare to its industry peersFastest return on investment - jammulinksnews.com
How does NRx Pharmaceuticals Inc. Equity Warrant generate profit in a changing economyRapid return acceleration - jammulinksnews.com
Is NRx Pharmaceuticals Inc. stock overvalued or undervaluedInvest smarter with cutting-edge analytics - jammulinksnews.com
NRx Pharmaceuticals Inc. Equity Warrant Company’s Quarterly Earnings Growth: What the Numbers SayFree Stock Market Swing Trading Strategies - metal.it
Should I hold or sell NRx Pharmaceuticals Inc. Equity Warrant stock in 2025Capitalize on fast-moving market trends - jammulinksnews.com
What is the risk reward ratio of investing in NRx Pharmaceuticals Inc. Equity Warrant stockPhenomenal trading returns - jammulinksnews.com
New to The Street Show #680 to Air on Bloomberg TV, Featuring DataVault, NRX Pharmaceuticals, FLOKI, Interlink Labs, and Arrive AI - AInvest
New to The Street Show #680 to Air Saturday, July 26 at 6:30 PM EST on Bloomberg TV - New Castle News
Is NRx Pharmaceuticals Inc. Equity Warrant a good long term investmentMarket-beating performance - PrintWeekIndia
NRx Pharmaceuticals Inc. Stock Analysis and ForecastAccelerated capital growth - PrintWeekIndia
What analysts say about NRx Pharmaceuticals Inc. stockExceptional ROI - PrintWeekIndia
What analysts say about NRx Pharmaceuticals Inc. Equity Warrant stockHigh-yield trading alerts - PrintWeekIndia
When is the best time to buy NRx Pharmaceuticals Inc. stockFree Stock Movement Tracking - jammulinksnews.com
What analysts say about NRx Pharmaceuticals Inc. stock outlookFree Wealth Management Insights - jammulinksnews.com
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Agreement to Acquire Interest in Cohen and Associates, LLC for HOPE's Network of Interventional Psychiatry Clinics - ADVFN Brasil
Is NRx Pharmaceuticals Inc. a good long term investmentHigh-octane gains - jammulinksnews.com
What drives NRx Pharmaceuticals Inc. Equity Warrant stock priceHigh-yield capital appreciation - jammulinksnews.com
Nrx Pharmaceuticals Inc Azioni (NRXP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
10.28%
2.59%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):